Low-Frequency Bladder Vibration Beneficial for UTI in Spinal Cord Injury
By Elana Gotkine HealthDay Reporter
THURSDAY, March 6, 2025 -- Applying low-frequency bladder vibration (LFBV) to patients with spinal cord injury (SCI)/neurogenic bladder who developed urinary tract infections (UTIs) during rehabilitation is associated with a reduction in urinary leukocytes and urinary bacteria on day 10, according to a study recently published in International Urology and Nephrology.
Yingying Zhang, from The First Affiliated Hospital of Soochow University in Suzhou, China, and colleagues conducted a single-blind randomized controlled trial involving patients who developed UTIs while rehabilitating from SCI. Participants were randomly assigned to a control or intervention group (44 and 43 patients, respectively); the intervention group received LFBV twice daily for 10 days.
The researchers found that the intervention group had significantly higher urinary leukocytes on day 2 and significantly lower urinary leukocytes and urinary bacteria on day 10 compared with the control group. The intervention group had significantly lower urinary leukocytes and postvoid residual volume, fewer signs and symptoms of UTI, and significantly higher urine volume four weeks after LFBV. No significant change was seen in urinary red blood cells or occult blood due to LFBV.
"The improvements were sustained up to four weeks after the intervention," the authors write. "It may be helpful to incorporate bladder vibration into the standard rehabilitation protocol for SCI patients."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-07 06:00
Read more

- Mortality Up for Individuals Who Need Hospital-Based Care for Cannabis Addiction
- Mass Shootings That Claim Most Kids' Lives Are Done by Family Members
- Daily Screen Time Tied to Higher Myopia Risk
- Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications
- Parents' Mental Health Impacts Kids' Risk of ADHD, Anxiety
- Could Your Cup of Tea Help Remove Lead From Drinking Water?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions